Opus Genetics, Inc.

IRD ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2018

Total Assets: $16.0M

Liabilities Breakdown FY2018

Total Liabilities: $5.5M